Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999-2008.
about
Standards of medical care in diabetes--2012Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular TrialsClinical review: Screening for coronary artery disease in type 2 diabetes.Standards of medical care in diabetes--2013Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetesSmoking behavior among US adults with diabetes or impaired fasting glucose.Effects of reduced β2-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice.Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease statusDifferences in statin usage and target-goal achievement between departments at the same hospitalSimilar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studiesTrends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort studyLow paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery diseaseTrends in the Risk for Cardiovascular Disease among Adults with Diabetes in Oman.Circulating malondialdehyde-modified LDL-related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetesRacial/ethnic- and education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetesGlycated human serum albumin isolated from poorly controlled diabetic patients impairs cholesterol efflux from macrophages: an investigation by mass spectrometry.Durability of glycemic control using U-500 insulin.Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study.Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey.Systematic review of published Phase 3 data on anti-PCSK9 monoclonal antibodies in patients with hypercholesterolaemia.Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study.Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes StudyThe imperative to prevent diabetesUnique and Varied Contributions of Traditional CVD Risk Factors: A Systematic Literature Review of CAD Risk Factors in China.Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR studyAssociation between Sleep Disruption and Levels of Lipids in Caucasians with Type 2 Diabetes.HbA1c measurement and relationship to incident stroke.The association between different A1C-based measures of glycemia and risk of cardiovascular disease hospitalization.Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013).Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus.Managing diabetes in patients with diabetes of long duration.Type 2 diabetes and cardiovascular disease in women.Revisiting the links between glycaemia, diabetes and cardiovascular disease.Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity.Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care.The impact of PRAISEDD on adherence and initiation of heart health behaviors in senior housing.Changes in characteristics and management of Asian and Anglo-Celts with type 2 diabetes over a 15-year period in an urban Australian community: The Fremantle Diabetes Study.
P2860
Q24632533-8FBB7A0A-F625-4D07-97A4-B9BD4E4E7B1AQ26767164-50D4192B-3CAD-4353-A470-CBB8C3CC0390Q26860716-96D27487-7982-4494-86B2-F140713AA0B6Q29620309-414C47B2-BDE8-48A6-8039-622B234D731CQ30234498-3042F809-2F56-4E5D-88F1-2122FFFCA699Q33834055-13B9E20C-D50D-4680-AAAD-89E1BE97849AQ34057028-C755A72E-3577-4B0E-8983-22D22FA58F65Q34116789-50E54224-0829-4441-8AAF-78FBFF3DC79AQ34199412-030D994D-BAC2-49A5-B2F9-946A3AFDFBE2Q34487808-444645BA-DA6A-4C9F-8D28-E5D3CB78B84AQ34515806-A57FCBA5-BD0D-4739-A616-CC7C40CE2D9BQ34548552-E4452FA4-AFDF-46E1-BEC7-D1A368C9FB16Q34611408-591FE886-3A37-44BB-A2D6-422DD474F7AEQ34626071-32180051-916A-435D-A0C6-7E30DE74700DQ35054054-C5090606-B986-49B8-9307-D829A9C2DBE3Q35341724-2F782577-2C6D-4C4D-99E7-54EFD6D462EEQ35688381-14EDBDFA-CB92-423C-9547-666B218C926BQ35755524-4A60B206-6382-46A6-9AFA-0B000B5FD3F1Q35783956-773319A5-E29C-4E30-B29C-4813E5502033Q35940798-7AEFD6B8-D394-47AB-9392-54C923696573Q35976508-C560CD1F-673C-4DC7-8A2B-B420E08732E7Q36091331-C84E411E-69EF-4B77-ADFB-7302B1BCDDF4Q36249641-62A851EA-66D0-4406-8B57-CC76F0FDE5E7Q36383377-469F7803-4DC6-4BE8-A35B-DEAC0DB183CEQ36426760-368E5FA9-810B-4705-8432-38C6DD18F8B6Q36758320-AE9C44EC-2101-4A32-9269-D4E3E065FCABQ36782780-E7A52F85-20F6-4CAC-8F15-EB1B10E90340Q37033651-851E96D0-BBC3-479D-91F9-92610A48B759Q37171941-54FB82F6-698A-42E1-A127-6C78A2D87ACEQ37344069-B8095585-CAD7-4D33-80BD-14B53607B045Q37403177-E1F17FB7-D164-4E44-8FEC-08D586AF8CC5Q37563912-1B261BDB-3B33-4E4A-ABFC-94CD2E0FCE6FQ37690751-8468C4D5-BEE3-442B-9295-34AC3DCAF2CBQ38015776-D15A9C74-37E2-4A0F-8526-4D5A816468CAQ38040307-3D36F367-9C46-40E4-A19F-A4021D211219Q38077060-752A1637-73F0-4527-918C-BE20C62552E9Q38213328-497BC2B9-BAA0-4295-9FC2-C7DA9F0CFFD6Q38657213-D0C42F87-79D1-4856-9E5A-F3B4BE21C008Q39338336-A1009DB2-6E61-485D-8061-E2C8786C12A9Q40249013-D6F63CE3-FE4B-4E3C-9C90-734E48BFC82D
P2860
Trends in the risk for coronary heart disease among adults with diagnosed diabetes in the U.S.: findings from the National Health and Nutrition Examination Survey, 1999-2008.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Trends in the risk for coronar ...... Examination Survey, 1999-2008.
@en
type
label
Trends in the risk for coronar ...... Examination Survey, 1999-2008.
@en
prefLabel
Trends in the risk for coronar ...... Examination Survey, 1999-2008.
@en
P2860
P356
P1433
P1476
Trends in the risk for coronar ...... Examination Survey, 1999-2008.
@en
P2093
Earl S Ford
P2860
P304
P356
10.2337/DC10-2251
P407
P577
2011-04-19T00:00:00Z